Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up (SEPTA PMCF)

NCT07209852 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT07209852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07209852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up (SEPTA PMCF)
Lead sponsor
Boston Scientific Corporation
Phase
Observational
Overall status
Recruiting
Start date
December 19, 2025
Completion date
August 31, 2029
Enrollment
140 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

atrioventricular block, bradycardia, bundle-branch block, sinus node dysfunction